A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/127 (2006.01) A61K 31/7088 (2006.01) A61K 31/7125 (2006.01) A61K 41/00 (2006.01) A61K 45/06 (2006.01) C12N 15/11 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2476437
The invention relates to the use of oliognucleotide containing cationic liposomal formulations to enhance the efficacy of chemotherapy and/or radiotherapy, particularly as a means to chemosensitize cancer are tumor tissues to the efficiencies of chemotherapy. This is particularly advantageous in the context of treatment of ras expressing tumors such as breast, lung, pancreatic and prostate cancer.
L'invention concerne l'utilisation de formulations liposomales cationiques contenant des oligonucl~otides en vue d'am~liorer l'efficacit~ de la chimioth~rapie et/ou de la radioth~rapie, notamment comme moyen pour chimiosensibiliser un cancer et des tissus tumoraux ~ l'action de la chimioth~rapie. Ces formulations sont particulirement avantageuses dans le contexte du traitement de tumeurs exprimant le gne ras telles que le cancer du sein, des poumons, du pancr~as et de la prostate.
Ahmad Imran
Dritschilo Anatoly
Gokhale Prafulla
Kasid Usha
Mewani Rajshree
Georgetown University
Marks & Clerk
Neopharm Inc.
LandOfFree
Chemosensitizing with liposomes containing oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemosensitizing with liposomes containing oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemosensitizing with liposomes containing oligonucleotides will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1568260